Liat Flaishon

Dr. Flaishon brings 20 years of experience in managing clinical trials in the pharmaceutical industry and as a board-certified internal medicine physician. Prior to joining BioSight, Dr. Flaishon served in several positions in the industry, including VP Clinical Affairs at Intec Pharma, a Phase 3 biotech company, where she led early and advanced clinical projects, and a Director of Drug Safety Risk Management Plans in the global Pharmacovigilance Department at Teva Pharmaceuticals, where she accompanied products from early development stages to commercialization. Dr. Flaishon served as an internal medicine physician at the Tel-Aviv Sourasky Medical Center. Dr. Flaishon holds a medical degree from Tel-Aviv University and a PhD degree in Immunology from the Weizmann Institute of Science.